![Alex Lenz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Mike Graffeo | M | - |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | 6 jaar |
Adam Feinberg | M | - |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | - |
Jon Stevenson | M | - |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | - |
Tim Richmond | M | 57 |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | - |
Jay Galeota | M | 57 |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | - |
Kevin Ladwig | M | - |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | - |
Phil Hellmuth | M | - |
Fluidform LLC
![]() Fluidform LLC Industrial MachineryProducer Manufacturing FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 7 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties